FDA adds Protégé to list of approved iliac stents

The FDA approved a self-expanding stent system for patients with peripheral artery disease, adding another option for treating blockages in the iliac arteries.

Medtronic received the all-clear to market its Protégé GPS self-expanding peripheral stent system as a treatment for stenotic lesions of the common and external iliac arteries. The agency based its approval on the nonrandomized DURABILITY trial, which showed a 95.8 percent patency rate, according to Medtronic.

The system incorporates a self-expanding nitinol stent with GPS markers at the proximal and distal ends that are designed to facilitate positioning. The Protégé device is compatible with a 6 French profile delivery system.

Candace Stuart, Contributor

Around the web

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."